FT-1101

N/A

Report date: 2022/12/28 20:00:47
NME

Base Information

Drug NameFT-1101
Drug Alias NameFT-1101CC-95775
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsMyelodysplastic SyndromesLymphoma, Non-HodgkinLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceSpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesForma Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesCelgene Corp
Inactive CompaniesForma Therapeutics Holdings Inc
Active IndicationsLymphoma, Non-Hodgkin
Inactive IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A